NEWS
Microbial CRDMO: Yaohai’s Path to Global Compliance
Biopharmaceutical developers pursuing simultaneous approvals in the United States, China, Europe, and Australia face a layered set of obstacles. Mammalian expression systems, long the default
October 30, 2026
No Comments
